• androgen receptor signaling pathway • chromatin remodeling • maintenance of chromatin silencing • regulation of transcription, DNA-templated • regulation of transcription from RNA polymerase II promoter • cardiac muscle cell differentiation • optic cup formation involved in camera-type eye development • nucleosome mobilization • placenta blood vessel development • negative regulation of transcription from RNA polymerase II promoter • toxin transport • chromatin organization • transcription, DNA-templated • nervous system development • cardiac chamber development • ATP-dependent chromatin remodeling • positive regulation of transcription, DNA-templated • neural tube closure • nucleosome disassembly • chromatin-mediated maintenance of transcription • forebrain development • intracellular estrogen receptor signaling pathway • glucocorticoid receptor signaling pathway • formation of primary germ layer • gastrulation • embryo implantation • stem cell population maintenance
Sources:Amigo / QuickGO
Orthologs
Species
Human
Mouse
Entrez
8289
93760
Ensembl
ENSG00000117713
ENSMUSG00000007880
UniProt
O14497
A2BH40
RefSeq (mRNA)
NM_139135 NM_006015 NM_018450
NM_001080819 NM_001363070
RefSeq (protein)
NP_006006 NP_624361
NP_001074288 NP_001349999
Location (UCSC)
Chr 1: 26.69 – 26.78 Mb
Chr 4: 133.68 – 133.76 Mb
PubMed search
[3]
[4]
Wikidata
View/Edit Human
View/Edit Mouse
AT-rich interactive domain-containing protein 1A is a protein that in humans is encoded by the ARID1A gene.[5][6][7]
Contents
1Function
2Clinical significance
3Research
4Interactions
5References
6Further reading
7External links
Function
ARID1A is a member of the SWI/SNF family, whose members have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodelling complex SWI/SNF, which is required for transcriptional activation of genes normally repressed by chromatin. It possesses at least two conserved domains that could be important for its function. First, it has an ARID domain, which is a DNA-binding domain that can specifically bind an AT-rich DNA sequence known to be recognized by a SWI/SNF complex at the beta-globin locus. Second, the C-terminus of the protein can stimulate glucocorticoid receptor-dependent transcriptional activation. It is thought that the protein encoded by this gene confers specificity to the SWI/SNF complex and may recruit the complex to its targets through either protein-DNA or protein-protein interactions. Two transcript variants encoding different isoforms have been found for this gene.[7]
Clinical significance
This gene has been commonly found mutated in gastric cancers,[8] ovarian clear cell carcinoma,[9] and pancreatic cancer.[10]
In breast cancer distant metastases acquire inactivation mutations in ARID1A not seen in the primary tumor, and reduced ARID1A expression confers resistance to different drugs such as trastuzumab and mTOR inhibitors. these findings provide a rationale for why tumors accumulate ARID1A mutations. [11][12]
Research
Lack of this gene/protein seems to protect rats from some types of liver damage.[13]
Interactions
ARID1A has been shown to interact with SMARCB1[14][15] and SMARCA4.[15][16]
References
^ abcGRCh38: Ensembl release 89: ENSG00000117713 - Ensembl, May 2017
^ abcGRCm38: Ensembl release 89: ENSMUSG00000007880 - Ensembl, May 2017
^Takeuchi T, Furihata M, Heng HH, Sonobe H, Ohtsuki Y (Aug 1998). "Chromosomal mapping and expression of the human B120 gene". Gene. 213 (1–2): 189–93. doi:10.1016/S0378-1119(98)00194-2. PMID 9630625.
^Takeuchi T, Chen BK, Qiu Y, Sonobe H, Ohtsuki Y (Feb 1998). "Molecular cloning and expression of a novel human cDNA containing CAG repeats". Gene. 204 (1–2): 71–7. doi:10.1016/S0378-1119(97)00525-8. PMID 9434167.
^ ab"Entrez Gene: ARID1A AT rich interactive domain 1A (SWI-like)".
^Wang K, Kan J, Yuen ST, Shi ST, Chu KM, Law S, Chan TL, Kan Z, Chan AS, Tsui WY, Lee SP, Ho SL, Chan AK, Cheng GH, Roberts PC, Rejto PA, Gibson NW, Pocalyko DJ, Mao M, Xu J, Leung SY (December 2011). "Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer". Nat. Genet. 43 (12): 1219–23. doi:10.1038/ng.982. PMID 22037554.
^Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, Yang W, Heravi-Moussavi A, Giuliany R, Chow C, Fee J, Zayed A, Prentice L, Melnyk N, Turashvili G, Delaney AD, Madore J, Yip S, McPherson AW, Ha G, Bell L, Fereday S, Tam A, Galletta L, Tonin PN, Provencher D, Miller D, Jones SJ, Moore RA, Morin GB, Oloumi A, Boyd N, Aparicio SA, Shih I-M, Mes-Masson AM, Bowtell DD, Hirst M, Gilks B, Marra MA, Huntsman DG (October 2010). "ARID1A mutations in endometriosis-associated ovarian carcinomas". N. Engl. J. Med. 363 (16): 1532–43. doi:10.1056/NEJMoa1008433. PMC 2976679. PMID 20942669.
^Shain AH, Giacomini CP, Matsukuma K, Karikari CA, Bashyam MD, Hidalgo M, Maitra A, Pollack JR (January 2012). "Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer". Proc. Natl. Acad. Sci. U.S.A. 109 (5): E252–9. doi:10.1073/pnas.1114817109. PMC 3277150. PMID 22233809.
^Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab Resistance.
Berns K et al; Clin Cancer Res. 2016 Nov 1;22(21):5238-5248
^Genomic Evolution of Breast Cancer Metastasis and Relapse.
Yates LR et al. Cancer Cell. 2017 Aug 14;32(2):169-184.e7. doi: 10.1016/j.ccell.2017.07.005.
^Tissue Regeneration Promoted through Gene Suppression. March 2016
^Kato H, Tjernberg A, Zhang W, Krutchinsky AN, An W, Takeuchi T, Ohtsuki Y, Sugano S, de Bruijn DR, Chait BT, Roeder RG (February 2002). "SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones". J. Biol. Chem. 277 (7): 5498–505. doi:10.1074/jbc.M108702200. PMID 11734557.
^ abWang W, Côté J, Xue Y, Zhou S, Khavari PA, Biggar SR, Muchardt C, Kalpana GV, Goff SP, Yaniv M, Workman JL, Crabtree GR (October 1996). "Purification and biochemical heterogeneity of the mammalian SWI-SNF complex". EMBO J. 15 (19): 5370–82. PMC 452280. PMID 8895581.
^Zhao K, Wang W, Rando OJ, Xue Y, Swiderek K, Kuo A, Crabtree GR (November 1998). "Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling". Cell. 95 (5): 625–36. doi:10.1016/S0092-8674(00)81633-5. PMID 9845365.
Martens JA, Winston F (2003). "Recent advances in understanding chromatin remodeling by Swi/Snf complexes". Curr. Opin. Genet. Dev. 13 (2): 136–42. doi:10.1016/S0959-437X(03)00022-4. PMID 12672490.
Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
Wang W, Xue Y, Zhou S, et al. (1996). "Diversity and specialization of mammalian SWI/SNF complexes". Genes Dev. 10 (17): 2117–30. doi:10.1101/gad.10.17.2117. PMID 8804307.
Wang W, Côté J, Xue Y, et al. (1996). "Purification and biochemical heterogeneity of the mammalian SWI-SNF complex". EMBO J. 15 (19): 5370–82. PMC 452280. PMID 8895581.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
Dallas PB, Cheney IW, Liao DW, et al. (1998). "p300/CREB binding protein-related protein p270 is a component of mammalian SWI/SNF complexes". Mol. Cell. Biol. 18 (6): 3596–603. PMC 108941. PMID 9584200.
Dallas PB, Pacchione S, Wilsker D, et al. (2000). "The human SWI-SNF complex protein p270 is an ARID family member with non-sequence-specific DNA binding activity". Mol. Cell. Biol. 20 (9): 3137–46. doi:10.1128/MCB.20.9.3137-3146.2000. PMC 85608. PMID 10757798.
Nie Z, Xue Y, Yang D, et al. (2000). "A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex". Mol. Cell. Biol. 20 (23): 8879–88. doi:10.1128/MCB.20.23.8879-8888.2000. PMC 86543. PMID 11073988.
Takeuchi T, Nicole S, Misaki A, et al. (2001). "Expression of SMARCF1, a truncated form of SWI1, in neuroblastoma". Am. J. Pathol. 158 (2): 663–72. doi:10.1016/S0002-9440(10)64008-4. PMC 1850330. PMID 11159203.
Kozmik Z, Machon O, Králová J, et al. (2001). "Characterization of mammalian orthologues of the Drosophila osa gene: cDNA cloning, expression, chromosomal localization, and direct physical interaction with Brahma chromatin-remodeling complex". Genomics. 73 (2): 140–8. doi:10.1006/geno.2001.6477. PMID 11318604.
Kato H, Tjernberg A, Zhang W, et al. (2002). "SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones". J. Biol. Chem. 277 (7): 5498–505. doi:10.1074/jbc.M108702200. PMID 11734557.
Lemon B, Inouye C, King DS, Tjian R (2002). "Selectivity of chromatin-remodelling cofactors for ligand-activated transcription". Nature. 414 (6866): 924–8. doi:10.1038/414924a. PMID 11780067.
Hurlstone AF, Olave IA, Barker N, et al. (2002). "Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein". Biochem. J. 364 (Pt 1): 255–64. doi:10.1042/bj3640255. PMC 1222568. PMID 11988099.
Inoue H, Furukawa T, Giannakopoulos S, et al. (2003). "Largest subunits of the human SWI/SNF chromatin-remodeling complex promote transcriptional activation by steroid hormone receptors". J. Biol. Chem. 277 (44): 41674–85. doi:10.1074/jbc.M205961200. PMID 12200431.
Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
Nie Z, Yan Z, Chen EH, et al. (2003). "Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner". Mol. Cell. Biol. 23 (8): 2942–52. doi:10.1128/MCB.23.8.2942-2952.2003. PMC 152562. PMID 12665591.
Kitagawa H, Fujiki R, Yoshimura K, et al. (2003). "The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome". Cell. 113 (7): 905–17. doi:10.1016/S0092-8674(03)00436-7. PMID 12837248.
External links
ARID1A+protein,+human at the US National Library of Medicine Medical Subject Headings (MeSH)
Human ARID1A genome location and ARID1A gene details page in the UCSC Genome Browser.
This article is about the capital of the Czech Republic. For other uses, see Prague (disambiguation). "Praha" redirects here. For other uses, see Praha (disambiguation). Capital city in Czech Republic Prague Praha Capital city Capital City of Prague Hlavní město Praha Clockwise from top: panorama with Prague Castle, Malá Strana and Charles Bridge; Pankrác district with high-rise buildings; street view in Malá Strana; Old Town Square panorama; gatehouse tower of the Charles Bridge; National Theatre Flag Coat of arms Motto(s): "Praga Caput Rei publicae" (Latin) [1] "Prague, Head of the Republic" .mw-parser-output .nobold{font-weight:normal} other historical mottos "Praga mater urbium" (Latin) "Praha matka měst" (Czech) [1] "Prague, Mother of Cities" "Praga Caput Regni" (Latin) [2] "Prague, Head of the Kingdom" Prague Location of Prague in the Cze...
Coordinates: 53°10′N 1°00′W / 53.167°N 1.000°W / 53.167; -1.000 County of England Nottinghamshire County Flag Motto: Sapienter proficiens (Progress with wisdom) Sovereign state United Kingdom Constituent country England Region East Midlands Established Historic Ceremonial county Lord Lieutenant Sir John Peace High Sheriff Nicholas R B Ebbs [1] (2018/19) Area 2,160 km 2 (830 sq mi) • Ranked 27th of 48 Population (mid-2017 est.) 1,147,100 • Ranked 15th of 48 Density 531/km 2 (1,380/sq mi) Ethnicity 94.1% White British/Irish/Other 2.5% South Asian 1.5% Afro-Caribbean Non-metropolitan county County council Nottinghamshire County Council Executive Labour Admin HQ West Bridgford Area 2,085 km 2 (805 sq mi) • Ranked 24th of 27 Population 817,900 • Ranked 10th of 27 Density 392/km 2 (1,020/sq mi) ISO 3166-2 GB-NTT ONS code 37 NUTS UKF15/16 Website ww...
Town in Massachusetts, United States Oxford, Massachusetts Town Oxford Town Hall Seal Location in Worcester County and the state of Massachusetts. Coordinates: 42°07′00″N 71°51′55″W / 42.11667°N 71.86528°W / 42.11667; -71.86528 Coordinates: 42°07′00″N 71°51′55″W / 42.11667°N 71.86528°W / 42.11667; -71.86528 Country United States State Massachusetts County Worcester Settled 1687 Incorporated 1713 Government • Type Open town meeting • Town Manager Jennifer Callahan Area • Total 27.5 sq mi (71.3 km 2 ) • Land 26.6 sq mi (69.0 km 2 ) • Water 0.9 sq mi (2.3 km 2 ) Elevation 508 ft (155 m) Population (2016) • Total 13,911 • Density 510/sq mi (200/km 2 ) Time zone UTC-5 (Eastern) • Summer (DST) UTC-4 (Eastern) ZIP code 01537, 01540 Area code(s) 508 / 774 FIPS code 25-51825 GNIS feature ID 0618379 Website http://www.town.oxford.ma.us/ Oxford is a town in Wo...
